ERAS
Erasca, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:58 PM EST
13.77USD-0.828%(-0.12)8,941,557
Pre-marketNov 18, 2026 9:25:30 AM EST
14.05USD+1.152%(+0.16)
After-hoursNov 18, 2026 4:42:30 PM EST
13.96USD+1.343%(+0.18)
Loading…
Loading…
4.84B
Healthcare
Biotechnology
HQ
San Diego, CA, USA
129
Previous Close
$13.89
Beta
1.74
52-Week High
$24.28 2026-04-23
52-Week Low
$2.71 2025-11-18
SMA 50
$14.89
SMA 200
$15.30
Avg. Vol 10D
6.68M
Avg. Vol 30D
5.53M
Avg. Vol 90D
4.74M
Relative Vol
1.62
350.96M
256.41M
73.06%
37,156,627
15.03%
8.89
58%/42%
66.17%
41.85%
0.4100%
6,000,000
351
62,657
220,366
-307.9M
-0.99
-109.2M
-48.7
Nov 18, 2026
Erasca at jefferies healthcare conference: r&d catalyst in focus ·
Investing.com
Nov 17, 2026
Why is Erasca stock sliding today? ·
Investing.com
ERAS Profile
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.
ERAS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 16.80 | 2026-11-11 | -17.98% | 0.343 |
| 1M | 13.62 | 2026-10-19 | +1.18% | 3.017 |
| 3M | 18.10 | 2026-08-18 | -23.87% | 2.687 |
| 6M | 10.27 | 2026-05-18 | +34.18% | 2.398 |
| 1Y | 2.86 | 2025-11-18 | +381.82% | 1.737 |
| 2Y | 2.73 | 2024-11-18 | +404.76% | — |
| 5Y | 18.22 | 2021-11-18 | -24.37% | 1.458 |
ERAS Stock Summary
Erasca, Inc. Common Stock (NASDAQ:ERAS) stock price today is $13.78, and today's volume is 8,941,557. ERAS is down 0.792% today. The 30 day average volume is 5.53M. ERAS market cap is $4.84B with 350.96M shares outstanding.